Meropenem Bradex (Meropenem Anhydrous)

Meropenem Bradex is a broad‑spectrum carbapenem used for serious bacterial infections that require intravenous therapy.

• Complicated intra‑abdominal infections: provides coverage against mixed aerobic and anaerobic pathogens to achieve clinical cure.
• Complicated urinary tract infections: eradicates resistant Gram‑negative organisms, facilitating resolution of infection.
• Nosocomial pneumonia: targets multidrug‑resistant bacteria in hospital‑acquired lung infections, improving patient outcomes.
• Septicemia: rapidly reduces bacterial load in bloodstream infections, supporting recovery.

• Meropenem inhibits bacterial cell wall synthesis by binding to penicillin‑binding proteins (PBPs). This binding disrupts the final transpeptidation step of peptidoglycan cross‑linking, leading to weakened cell walls and bacterial lysis. Its high affinity for a broad range of PBPs gives it activity against many Gram‑negative and Gram‑positive organisms, including those resistant to other β‑lactam antibiotics.

Adverse reactions may occur with any intravenous antibiotic and should be monitored during therapy.

Common Side Effects

• Diarrhea: mild to moderate loose stools.
• Nausea: occasional feeling of queasiness.
• Rash: transient skin erythema or pruritus.
• Elevated liver enzymes: mild transaminase increase.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction requiring immediate medical attention.
• Seizures: especially in patients with renal impairment or high doses.
• Clostridioides difficile colitis: severe intestinal inflammation.
• Hemolytic anemia: rare immune‑mediated destruction of red blood cells.

Use Meropenem Bradex only under medical supervision, considering patient‑specific factors.

• Renal function: adjust dose in patients with impaired kidney function.
• Seizure risk: monitor neurologic status, especially in those with pre‑existing CNS disorders.
• Allergy history: avoid in patients with known β‑lactam hypersensitivity.
• Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited.
• Drug interactions: review concomitant medications for potential synergistic toxicity.

Store at ambient temperature: keep in original container, protect from moisture and light.

Meropenem Bradex may interact with other agents that affect renal clearance or lower seizure threshold.

Major Interactions (Avoid)

• Valproic acid: may reduce antiepileptic efficacy and increase toxicity.
• Aminoglycosides: combined nephrotoxicity risk; avoid concurrent high‑dose therapy.

Moderate Interactions (Monitor Closely)

• Loop diuretics: may increase risk of ototoxicity when used with other nephrotoxic drugs.
• Probenecid: can decrease renal excretion, raising meropenem plasma levels.
• Other β‑lactams: additive risk of hypersensitivity reactions.